Concepedia
Statistics
Publications
19
Citations
512
H-Index
15
Active since
1991
Affiliations
Mochida Pharmaceutical (Japan)(Current)
Astellas Pharma (Japan)
Okayama University
The University of Osaka
Fujisawa City Hospital
Susumu Tsujimoto is an author at Mochida Pharmaceutical (Japan) specializing in medicine, pharmacology, and immunology.
Top concepts
MedicinePharmacologyImmunologyTumor BiologyPharmacotherapyPathologyPhysiologyInflammationCancer BiologyDrug Discovery
Publications per year
1991–2016
Intratumoral injection of oligonucleotides to the NFκB binding site inhibits cachexia in a mouse tumor model
Ikuo Kawamura, Ryuichi Morishita, Naohiro Tomita et al. · Gene Therapy · 1999 · 117 citations
Medicine, Mouse Tumor Model, Cell Biology +7
Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice
Ikuo Kawamura, Ryuichi Morishita, Susumu Tsujimoto et al. · Gene Therapy · 2001 · 54 citations
Tumor Biology, Oncology, Intravenous Injection +10
Anti-inflammatory activity of non-nucleoside adenosine deaminase inhibitor FR234938
Masako Kuno, Nobuo Seki, Susumu Tsujimoto et al. · European Journal of Pharmacology · 2006 · 46 citations
Inflammation, Inhibitory Activity, Anti-inflammatory +5
FK317: a novel substituted dihydrobenzoxazine with potent antitumor activity which does not induce vascular leak syndrome
Yoshinori Naoe, Masamichi Inami, S Matsumoto et al. · Cancer Chemotherapy and Pharmacology · 1998 · 43 citations
Medicinal Chemistry, Pharmacology, Potent Antitumor Activity +9
Cytotoxic Mechanisms of FK317, a New Class of Bioreductive Agent with Potent Antitumor Activity
Yoshinori Naoe, Masamichi Inami, Ikuo Kawamura et al. · Japanese Journal of Cancer Research · 1998 · 23 citations · Full text
1–5 of 19